Trans-pQTL study identifies immune crosstalk between Parkinson and Alzheimer loci
Citation Manager Formats
Make Comment
See Comments

Abstract
Objective: Given evidence from genetic studies, we hypothesized that there may be a shared component to the role of myeloid function in Parkinson and Alzheimer disease (PD and AD) and assessed whether PD susceptibility variants influenced protein expression of well-established AD-associated myeloid genes in human monocytes.
Methods: We repurposed data in which AD-related myeloid proteins CD33, TREM1, TREM2, TREML2, TYROBP, and PTK2B were measured by flow cytometry in monocytes from 176 participants of the PhenoGenetic Project (PGP) and Harvard Aging Brain Study. Linear regression was used to identify associations between 24 PD risk variants and protein expression. The 2 cohorts were meta-analyzed in a discovery analysis, and the 4 most strongly suggestive results were validated in an independent cohort of 50 PGP participants.
Results: We discovered and validated an association between the PD risk allele rs12456492G in the RIT2 locus and increased CD33 expression (pjoint = 3.50 × 10−5) and found strongly suggestive evidence that rs11060180A in the CCDC62/HIP1R locus decreased PTK2B expression (pjoint = 1.12 × 10−4). Furthermore, in older individuals, increased CD33 expression on peripheral monocytes was associated with a greater burden of parkinsonism (p = 0.047), particularly bradykinesia (p = 6.64 × 10−3).
Conclusions: We find that the rs12456492 PD risk variant affects expression of AD-associated protein CD33 in peripheral monocytes, which suggests that genetic factors for these 2 diseases may converge to influence overlapping innate immune-mediated mechanisms that contribute to neurodegeneration. Furthermore, the effect of the rs12456492G PD risk allele on increased CD33 suggests that the inhibition of certain myeloid functions may contribute to PD susceptibility, as is the case for AD.
GLOSSARY
- AD=
- Alzheimer disease;
- DLPFC=
- dorsolateral prefrontal cortex;
- eQTL=
- expression quantitative trait locus;
- GWAS=
- genome-wide association study;
- HABS=
- Harvard Aging Brain Study;
- PD=
- Parkinson disease;
- PGP=
- PhenoGenetic Project;
- pQTL=
- protein quantitative trait locus;
- ROS-MAP=
- Religious Orders Study and Memory and Aging Project;
- SNP=
- single nucleotide polymorphism
Footnotes
↵* Co-last authors.
Funding information and disclosures are provided at the end of the article. Go to Neurology.org/ng for full disclosure forms. The Article Processing Charge was paid by the authors.
Supplemental data at Neurology.org/ng
- Received March 15, 2016.
- Accepted in final form June 15, 2016.
- © 2016 American Academy of Neurology
This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND), which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Sevil Yaşar and Dr. Behnam Sabayan
► Watch
Topics Discussed
Alert Me
Recommended articles
-
Article
Genetic architecture of age-related cognitive decline in African AmericansTowfique Raj, Lori B. Chibnik, Cristin McCabe et al.Neurology: Genetics, December 21, 2016 -
Article
The TMEM106B locus and TDP-43 pathology in older persons without FTLDLei Yu, Philip L. De Jager, Jingyun Yang et al.Neurology, February 04, 2015 -
Article
Relation of genomic variants for Alzheimer disease dementia to common neuropathologiesJose M. Farfel, Lei Yu, Aron S. Buchman et al.Neurology, July 01, 2016 -
Article
Genetic risk scores and hallucinations in patients with Parkinson diseaseCynthia D.J. Kusters, Kimberly C. Paul, Aline Duarte Folle et al.Neurology: Genetics, July 20, 2020